SCHEMBL15076013

SCHEMBL15076013

COc1ccc(C(=O)CCC(=O)N[C@@H](Cc2ccc(F)c(C(F)(F)F)c2)B(O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 3/20 0.50
TP53 P04637 2/20 0.48
MMP1 P03956 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PARP1 P09874 1/20 0.41
GAA P10253 1/20 0.41
THRB P10828 1/20 0.41
MAPT P10636 2/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
PTPN7 P35236 1/20 0.40
DUSP3 P51452 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16280512 1.00 PSMB5 (0.50) PSMB5TP53MMP1SMN1; SMN2MEN1
SCHEMBL15076043 0.91 PSMB5 (0.50) PSMB5TP53MMP1SMN1; SMN2MEN1
SCHEMBL15076026 0.91 PSMB5 (0.50) PSMB5TP53MMP1SMN1; SMN2MEN1
SCHEMBL15058310 0.87 TP53 (0.49) TP53MMP1SMN1; SMN2MEN1KMT2A
SCHEMBL15075897 0.84 PSMB5 (0.48) PSMB5TP53MMP1SMN1; SMN2MEN1
SCHEMBL15058718 0.83 PSMB5 (0.57) PSMB5TP53MMP1MEN1KMT2A
SCHEMBL15058715 0.83 PSMB5 (0.57) PSMB5TP53MMP1MEN1KMT2A
SCHEMBL19034212 0.81 POLB (0.46) PSMB5TP53MMP1SMN1; SMN2MEN1
SCHEMBL16280177 0.81 PSMB5 (0.52) PSMB5TP53MMP1SMN1; SMN2MEN1
SCHEMBL15075861 0.81 PSMB5 (0.52) PSMB5TP53MMP1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2793900-B1 ALPHA-AMINO BORONIC ACID DERIVATIVES, SELECTIVE IMMUNOPROTEASOME INHIBITORS ARES TRADING SA (CH) 2018-08-22 EP disclosed
US-9688702-B2 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors ARES TRADING (CH) 2017-06-27 US disclosed
US-9688702-B2 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors ARES TRADING (CH) 2017-06-27 US disclosed
US-9688702-B2 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors ARES TRADING (CH) 2017-06-27 US disclosed
US-20140364396-A1 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors ARES TRADING SA (CH) 2014-12-11 US disclosed
US-20140364396-A1 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors ARES TRADING SA (CH) 2014-12-11 US disclosed
US-20140364396-A1 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors ARES TRADING SA (CH) 2014-12-11 US disclosed
WO-2013092979-A1 ALPHA-AMINO BORONIC ACID DERIVATIVES, SELECTIVE IMMUNOPROTEASOME INHIBITORS ARES TRADING S.A. (CH) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140364396-A1 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors PSMB7, PSMA7, PSMB1 PSMB5 5/4885TP53 1038/4885MMP1 2452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.